Symptoms may include shakiness, sweating, dizziness, confusion, or even loss of consciousness
Its impressive effects on weight reduction and potential cardiovascular benefits have drawn attention, with ongoing studies exploring its potential in non-alcoholic steatohepatitis (NASH) and Alzheimer's disease
The change comes as patents on semaglutide, the active ingredient in Ozempic and related drugs like Wegovy, begin expiring in Canada, India, China and Brazil, Bloomberg reports
Tzivian L, Sokolovska J, Grike AE, et al
SmartShape also offers financing options for patients
[147] It is also available for obesity, limited to treatment for two years